Id |
Subject |
Object |
Predicate |
Lexical cue |
T348 |
0-178 |
Sentence |
denotes |
The anti-inflammatory action of mesenchymal stem cells is well known, and it is believed that these mesenchymal stem cells exhibit anti-inflammatory action through PGE2 and LXA4. |
T349 |
179-361 |
Sentence |
denotes |
These lipids mediators alleviate the SARS-CoV-2 cytokine storm, while arachidonic acid, dihomo-gamma-linolenic acid, and gamma-linolenic acid inactivate enveloped viruses (Das 2020). |
T350 |
362-496 |
Sentence |
denotes |
Obesity is a risk factor for SARS-CoV-2 infection, and a BMI of 30 kg/m2 increases the risk of infection by 61% (Bello-Chavolla et al. |
T351 |
497-503 |
Sentence |
denotes |
2020). |
T352 |
504-652 |
Sentence |
denotes |
This is likely due to a deficiency of SPMs in obese patients, and this deficiency promotes adverse reactions during SARS-CoV-2 infection (Pal et al. |
T353 |
653-659 |
Sentence |
denotes |
2020). |
T354 |
660-785 |
Sentence |
denotes |
LXA4, Elovanoid-N32 or RvD6 isomers reduced expression of angiotensin-converting enzyme 2 (ACE2), but NDP1 did not reduce it. |
T355 |
786-956 |
Sentence |
denotes |
These lipids mediators also counteract the binding of the receptor-binding domain (RBD) of SARS-CoV-2 spike (S) protein to the injured cornea (Figs. 3 and 4) (Pham et al. |
T356 |
957-963 |
Sentence |
denotes |
2020). |
T357 |
964-1089 |
Sentence |
denotes |
Elovanoid-N32 or RvD6 isomers also attenuated the expression of cytokines involved in a cytokine storm and hyperinflammation. |
T358 |
1090-1320 |
Sentence |
denotes |
Based on previous study results that have demonstrated SPMs as potential therapeutic targets for SARS-CoV-2 infection, studies and review on the use of fish oil, an SPMs precursor, as an adjuvant are in progress. (Torrinhas et al. |
T359 |
1321-1340 |
Sentence |
denotes |
2020; Rogero et al. |
T360 |
1341-1347 |
Sentence |
denotes |
2020). |
T361 |
1348-1620 |
Sentence |
denotes |
SPMs and soluble epoxide hydrolase inhibitors are currently in clinical trials for other inflammatory diseases and can be quickly converted and used for SARS-CoV-2 management through the removal of cellular debris and inhibition of inflammatory cytokines (Panigrahy et al. |
T362 |
1621-1627 |
Sentence |
denotes |
2020). |